Cixutumumab
Cixutumumab (IMC-A12) is a human anti-IGF-1R monoclonal antibody with high affinity that inhibits ligand-dependent receptor activation and downstream signaling. Cixutumumab also mediates the internalization and degradation of IGF-IR. Cixutumumab shows broad-spectrum anti-tumour activity and can be used in studies of cancers such as lung cancer, malignancies, leukaemia, non-small cell lung cancer and prostate cancer[1].
Product Specifications
CAS Number
947687-12-9
Product Name Alternative
IMC-A12; NSC742460
UNSPSC
12352203
Target
IGF-1R
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cixutumumab.html
Purity
99.63
Solubility
10 mM in DMSO
Smiles
[Cixutumumab]
Molecular Weight
(150 kDa)
References & Citations
[1]Houghton PJ, et al. Initial testing of a monoclonal antibody (IMC-A12) against IGF-1R by the Pediatric Preclinical Testing Program. Pediatr Blood Cancer. 2010 Jul 1;54 (7) :921-6.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![PE/Cyanine7 Anti-Mouse CD272/BTLA Antibody[PK18.6]](https://cdn.genprice.uk/products/763/68dd149d061270361e7cfaa4/imageurl/e-ab-f1024uh.webp)
E-AB-F1024UH-01 25 µg
PE/Cyanine7 Anti-Mouse CD272/BTLA Antibody[PK18.6]
Sign In for Pricing
View Details E-AB-F1024UH-02 100 µg
PE/Cyanine7 Anti-Mouse CD272/BTLA Antibody[PK18.6]
Sign In for Pricing
View Details